Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
David P. Hochman | Director, Chairman of the Board | $1.26 M | Feb 10, 2022 | ||
Darren Sherman | Director | $1.15 M | Feb 10, 2022 | ||
Mark Pomeranz | President and COO, Director | $133 K | Feb 10, 2022 | ||
Andrew Lawrence Taylor | Chief Financial Officer | $118 K | Feb 10, 2022 | ||
Shervin J. Korangy | Director | $97.1 K | Feb 10, 2022 | ||
Elad Amor | Chief Accounting Officer | Jun 2, 2023 | |||
Sonja Nelson | Director | Mar 5, 2024 | |||
Ravit Ram | Chief Financial Officer | Jun 2, 2023 | |||
Timothy P. Moran | Director | Mar 5, 2024 | |||
Orchestra BioMed Holdings, Inc. | 10%+ Owner | Sep 12, 2023 | |||
Scott Durbin | Director | Mar 5, 2024 | |||
Gary J. Pruden | Director | Mar 5, 2024 |
Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
---|